An article written by MBHB partner Kevin E. Noonan, Ph.D., published in GeneWatch

MBHB partner Kevin E. Noonan, Ph.D., authored an article, Why Genes Must Remain Eligible for Patenting, that was recently published on the Council for Responsible Genetics’ GeneWatch website.

To read this article, click here.

Search
Menu
Menu